CA2581337A1 - Compositions enantiomeres de cicletanine, seules ou combinees a d'autres agents, utilisees a des fins therapeutiques - Google Patents

Compositions enantiomeres de cicletanine, seules ou combinees a d'autres agents, utilisees a des fins therapeutiques Download PDF

Info

Publication number
CA2581337A1
CA2581337A1 CA002581337A CA2581337A CA2581337A1 CA 2581337 A1 CA2581337 A1 CA 2581337A1 CA 002581337 A CA002581337 A CA 002581337A CA 2581337 A CA2581337 A CA 2581337A CA 2581337 A1 CA2581337 A1 CA 2581337A1
Authority
CA
Canada
Prior art keywords
cicletanine
hypertension
diabetes
blood
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002581337A
Other languages
English (en)
Inventor
Glenn Cornett
Jim Page
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Sciences Inc
Original Assignee
Glenn Cornett
Jim Page
Gilead Sciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/035,308 external-priority patent/US20060153934A1/en
Priority claimed from US11/035,328 external-priority patent/US20060154959A1/en
Priority claimed from US11/035,231 external-priority patent/US20060154971A1/en
Priority claimed from US11/232,724 external-priority patent/US20060089374A1/en
Application filed by Glenn Cornett, Jim Page, Gilead Sciences, Inc. filed Critical Glenn Cornett
Publication of CA2581337A1 publication Critical patent/CA2581337A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002581337A 2004-09-22 2005-09-22 Compositions enantiomeres de cicletanine, seules ou combinees a d'autres agents, utilisees a des fins therapeutiques Abandoned CA2581337A1 (fr)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US61232304P 2004-09-22 2004-09-22
US61236904P 2004-09-22 2004-09-22
US60/612,369 2004-09-22
US60/612,323 2004-09-22
US11/035,231 2005-01-13
US11/035,308 US20060153934A1 (en) 2005-01-13 2005-01-13 Combination therapies of cicletanine and magnesium
US11/035,328 US20060154959A1 (en) 2005-01-13 2005-01-13 Combination therapies of cicletanine and carvedilol
US11/035,328 2005-01-13
US11/035,231 US20060154971A1 (en) 2005-01-13 2005-01-13 Combination therapies of cicletanine and lacidipine
US11/035,308 2005-01-13
US68468405P 2005-05-26 2005-05-26
US60/684,684 2005-05-26
US11/232,724 2005-09-21
US11/232,724 US20060089374A1 (en) 2003-07-17 2005-09-21 Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
PCT/US2005/034763 WO2006034510A2 (fr) 2004-09-22 2005-09-22 Compositions enantiomeres de cicletanine, seules ou combinees a d'autres agents, utilisees a des fins therapeutiques

Publications (1)

Publication Number Publication Date
CA2581337A1 true CA2581337A1 (fr) 2006-03-30

Family

ID=36090724

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002581337A Abandoned CA2581337A1 (fr) 2004-09-22 2005-09-22 Compositions enantiomeres de cicletanine, seules ou combinees a d'autres agents, utilisees a des fins therapeutiques

Country Status (3)

Country Link
EP (1) EP1804795A4 (fr)
CA (1) CA2581337A1 (fr)
WO (1) WO2006034510A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
KR101701943B1 (ko) 2009-11-13 2017-02-02 도레이 카부시키가이샤 당뇨병의 치료 또는 예방약

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156817B (fr) * 1981-02-10 1985-11-09 Scras
WO1995006648A1 (fr) * 1993-09-03 1995-03-09 Kyowa Hakko Kogyo Co., Ltd. Derive d'imidazoquinazoline
HUP0300990A2 (hu) * 2003-04-15 2005-05-30 SynoSens Kutató és Fejlesztő Kft. Szinergista gyógyszer-kombináció a diabetesz megelőzésére vagy kezelésére
WO2005009446A1 (fr) * 2003-07-17 2005-02-03 Cotherix, Inc. Polytherapies destinees au traitement de l'hypertension et de complications chez des patients souffrant de diabetes ou du syndrome metabolique
WO2005021039A1 (fr) * 2003-08-29 2005-03-10 Cotherix, Inc. Combinaison de cicletanine et antidiabetique a administration orale et/ou agent de reduction des lipides sanguins en vue du traitement du diabete et du syndrome metabolique

Also Published As

Publication number Publication date
WO2006034510A3 (fr) 2006-06-01
WO2006034510A2 (fr) 2006-03-30
EP1804795A2 (fr) 2007-07-11
EP1804795A4 (fr) 2007-11-07

Similar Documents

Publication Publication Date Title
US20120289542A1 (en) Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
US20060089374A1 (en) Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
US20110250142A1 (en) Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
US20070141174A1 (en) Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
EP1507529B1 (fr) Combinaison comprenant valsartane, amlodipine et hydrochlorothiazide
AU2005314133B2 (en) Ibudilast for treating neuropathic pain and associated syndromes
CA2814518C (fr) Compositions et methodes de traitement de l'hypertension arterielle pulmonaire
BRPI0620234A2 (pt) combinação farmacêutica para o tratamento de luts que compreende um inibidor da pde5 e um antagonista muscarìnico
KR20070095279A (ko) 고지혈증 치료 방법 및 조성물
BRPI0616344A2 (pt) mÉtodo para o tratamento de dependÊncia quÍmica e comportamental
AU2006321942A1 (en) Methods and compositions for the treatment of disease
US20080096915A1 (en) Compositions for the treatment of metabolic disorders
EP3525779A1 (fr) Combinaison contenant des stimulateurs gcs et des antagonistes du récepteur des minéralocorticoïdes
KR20210139293A (ko) 폐동맥 고혈압 및 연관 폐동맥 고혈압 치료방법 및 매일 투여
WO2006128035A2 (fr) Compositions enantiomeres de cicletanine, combinees a d'autres agents, pour le traitement de l'hypertension
KR20050106038A (ko) 심장질환 및 신장질환의 치료를 위한 아데노신 ａ1 수용체길항제
CA2581337A1 (fr) Compositions enantiomeres de cicletanine, seules ou combinees a d'autres agents, utilisees a des fins therapeutiques
US20110251396A1 (en) Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
FR2556216A1 (fr) Nouveau medicament analgesique contenant du proglumide, eventuellement en association avec des medicaments analgesiques-narcotiques
CA2766937A1 (fr) Preparation combinee pour une utilisation en tant que medicament
US20040106582A1 (en) Use of mglur5 antagonists for the treatment of pruritic conditions
WO2015069839A1 (fr) Polythérapie pour le traitement de l'hypertension pulmonaire
CA2565616A1 (fr) Medicaments contenant de la pyrroloquinoline quinone pour le traitement de blessures cardiaques
WO2005042022A2 (fr) Combinaison nouvelle
US20060154971A1 (en) Combination therapies of cicletanine and lacidipine

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20150922